drugset / Trial / NCT03339544

Celebrex Premedication in Teeth With Symptomatic Irreversible Pulpitis

NCT03339544

Unknown 46 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

Assessing the efficacy of Celebrex premedication on pain during and after endodontic treatment in teeth with symptomatic irreversible pulpits

Timeline

Start
2017-12-01
Primary completion
2018-12-01
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg

Indications